EFFECTS OF GLYCOXIDATION ON COGNITION

糖氧化对认知的影响

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This young investigator pilot project will examine the effects of glycoxidation (advanced glycation end products, AGEs) on cognition in a sample of non-demented elderly participants and lay the foundation for a larger longitudinal study. AGEs have been proposed as an explanation why age and diabetes are risk factors for AD. Nonetheless, AGEs have never been studied prospectively as a risk factor for cognitive decline. Particularly, since they are modifiable by diet, AGEs are very exciting potential candidates for later prevention and treatment studies. The proposed study will build on an ongoing longitudinal study (PI- Dr. Helen Vlassara- Director of the Division of Diabetes and Aging, Department of Geriatrics, at Mount Sinai School of Medicine) examining the age-dependent relationships among circulating AGE and (dietary) AGE intake, markers of oxidative stress, inflammatory markers, and vascular dysfunction in subjects over the age of 60. In the proposed study, subjects will be cognitively assessed by the Clinical Dementia Rating scale, MMSE and the extensive neuropsychological battery of the Alzheimer's Disease Research Center (ADRC) at Mount Sinai, and evaluated by the ADRC consensus diagnostic conference, both at baseline and at follow up. In addition, at baseline, we will collect DNA for APOE and future genetic studies. Findings from this study may identify AGEs as a new modifiable environmental risk factor, acting together with endogenous mechanisms, negatively affecting cognition. This naturalistic cross-sectional and longitudinal study holds the potential to support future interventions to reduce the impact of AGEs, to prevent or delay cognitive decline in the elderly who are at increasing risk of dementia and AD. Hypotheses: 1- Main hypothesis: Subjects with higher levels of AGEs will show poorer cognitive functioning at baseline. 2- Exploratory hypothesis: Subjects with higher baseline AGEs or larger increases in AGEs over time will show a greater degree of cognitive decline. 3- Exploratory hypothesis: APOE4 will intensify the hypothesized relationships in Hypothesis 1.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。这个年轻的研究者试点项目将检查糖氧化(晚期糖基化终产物,AGEs)对非痴呆老年参与者样本认知的影响,并为更大规模的纵向研究奠定基础。AGEs已被提出来解释为什么年龄和糖尿病是AD的危险因素。然而,AGEs从未被作为认知能力下降的风险因素进行过前瞻性研究。特别是,由于它们可以通过饮食改变,AGEs是非常令人兴奋的潜在候选人,用于以后的预防和治疗研究。 拟议的研究将建立在一项正在进行的纵向研究(PI-Helen Vlassara博士-西奈山医学院老年病系糖尿病和衰老科主任)的基础上,该研究检查了60岁以上受试者中循环AGE和(饮食)AGE摄入量、氧化应激标志物、炎症标志物和血管功能障碍之间的年龄依赖性关系。 在拟议的研究中,受试者将在基线和随访时通过临床痴呆评定量表、简易智能状态检查量表和西奈山阿尔茨海默病研究中心(ADRC)的广泛神经心理学组合进行认知评估,并由ADRC共识诊断会议进行评估。此外,在基线时,我们将收集DNA用于APOE和未来的遗传研究。 这项研究的结果可能会确定AGEs作为一个新的可改变的环境风险因素,与内源性机制一起作用,对认知产生负面影响。这项自然的横断面和纵向研究有可能支持未来的干预措施,以减少AGEs的影响,预防或延迟痴呆和AD风险增加的老年人的认知能力下降。 假设:1-主要假设:AGEs水平较高的受试者在基线时表现出较差的认知功能。2-探索性假设:基线AGEs较高或AGEs随时间增加较大的受试者将表现出更大程度的认知下降。3-探索性假设:APOE 4将强化假设1中的假设关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michal Schnaider Beeri其他文献

Michal Schnaider Beeri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michal Schnaider Beeri', 18)}}的其他基金

Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimer's pathology and cerebrovascular disease
2型糖尿病相关认知能力下降和痴呆事件中的全身和饮食晚期糖基化终末产物:对阿尔茨海默病病理学和脑血管疾病的影响
  • 批准号:
    10429574
  • 财政年份:
    2019
  • 资助金额:
    $ 0.48万
  • 项目类别:
Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimer's pathology and cerebrovascular disease
2型糖尿病相关认知能力下降和痴呆事件中的全身和饮食晚期糖基化终末产物:对阿尔茨海默病病理学和脑血管疾病的影响
  • 批准号:
    10532448
  • 财政年份:
    2019
  • 资助金额:
    $ 0.48万
  • 项目类别:
Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimer's pathology and cerebrovascular disease
2型糖尿病相关认知能力下降和痴呆事件中的全身和饮食晚期糖基化终末产物:对阿尔茨海默病病理学和脑血管疾病的影响
  • 批准号:
    10533259
  • 财政年份:
    2019
  • 资助金额:
    $ 0.48万
  • 项目类别:
Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimer's pathology and cerebrovascular disease
2型糖尿病相关认知能力下降和痴呆事件中的全身和饮食晚期糖基化终末产物:对阿尔茨海默病病理学和脑血管疾病的影响
  • 批准号:
    10755501
  • 财政年份:
    2019
  • 资助金额:
    $ 0.48万
  • 项目类别:
Peripheral and brain levels of advanced glycation end products AGEs and incident Alzheimers disease and neuropathology
晚期糖基化终末产物 AGE 的外周和大脑水平以及阿尔茨海默病和神经病理学
  • 批准号:
    9741012
  • 财政年份:
    2016
  • 资助金额:
    $ 0.48万
  • 项目类别:
Peripheral and brain levels of advanced glycation end products AGEs and incident Alzheimers disease and neuropathology
晚期糖基化终末产物 AGE 的外周和大脑水平以及阿尔茨海默病和神经病理学
  • 批准号:
    9339522
  • 财政年份:
    2016
  • 资助金额:
    $ 0.48万
  • 项目类别:
Long term instability of glycemic control and hippocampal function
血糖控制和海马功能的长期不稳定
  • 批准号:
    8637483
  • 财政年份:
    2014
  • 资助金额:
    $ 0.48万
  • 项目类别:
Long term instability of glycemic control and hippocampal function
血糖控制和海马功能的长期不稳定
  • 批准号:
    8919974
  • 财政年份:
    2014
  • 资助金额:
    $ 0.48万
  • 项目类别:
Inflammation, long-term diabetes characteristics, and cognitive decline
炎症、长期糖尿病特征和认知能力下降
  • 批准号:
    8127916
  • 财政年份:
    2009
  • 资助金额:
    $ 0.48万
  • 项目类别:
Inflammation, long-term diabetes characteristics, and cognitive decline
炎症、长期糖尿病特征和认知能力下降
  • 批准号:
    8409860
  • 财政年份:
    2009
  • 资助金额:
    $ 0.48万
  • 项目类别:

相似国自然基金

基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
儿童音乐能力发展对语言与社会认知能力及脑发育的影响
  • 批准号:
    31971003
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
情感与视觉记忆:它们的相互作用及神经环路研究
  • 批准号:
    91132302
  • 批准年份:
    2011
  • 资助金额:
    300.0 万元
  • 项目类别:
    重大研究计划
儿童植入耳蜗后听觉行为与言语发展进程的关联性研究
  • 批准号:
    81170916
  • 批准年份:
    2011
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目
基于Situated Cognition的适应性概念设计方法学研究
  • 批准号:
    50505025
  • 批准年份:
    2005
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
  • 批准号:
    10748606
  • 财政年份:
    2024
  • 资助金额:
    $ 0.48万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 0.48万
  • 项目类别:
Individual Predoctoral Fellowship
个人博士前奖学金
  • 批准号:
    10752036
  • 财政年份:
    2024
  • 资助金额:
    $ 0.48万
  • 项目类别:
Canadian Consortium on Neurodegeneration in Aging: Application for Phase III CCNA Operations Centre
加拿大老龄化神经退行性疾病联盟:申请第三期 CCNA 运营中心
  • 批准号:
    497895
  • 财政年份:
    2023
  • 资助金额:
    $ 0.48万
  • 项目类别:
    Directed Grant
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
  • 批准号:
    10555899
  • 财政年份:
    2023
  • 资助金额:
    $ 0.48万
  • 项目类别:
Assessing and Improving the Durability of Compensatory Cognitive Training for Older Veterans (AID-CCT)
评估和提高老年退伍军人补偿性认知训练的持久性 (AID-CCT)
  • 批准号:
    10636523
  • 财政年份:
    2023
  • 资助金额:
    $ 0.48万
  • 项目类别:
Cognitively engaging walking exercise and neuromodulation to enhance brain function in older adults
认知性步行锻炼和神经调节可增强老年人的大脑功能
  • 批准号:
    10635832
  • 财政年份:
    2023
  • 资助金额:
    $ 0.48万
  • 项目类别:
Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease
线粒体脂质组动力学及其与 APOE 亚型的相互作用对脑衰老和阿尔茨海默病的影响
  • 批准号:
    10645610
  • 财政年份:
    2023
  • 资助金额:
    $ 0.48万
  • 项目类别:
Physical Activity and Weight Loss to Improve Function and Pain after Total Knee Replacement
体力活动和减肥可改善全膝关节置换术后的功能和疼痛
  • 批准号:
    10711058
  • 财政年份:
    2023
  • 资助金额:
    $ 0.48万
  • 项目类别:
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia
GPR39 作为衰老相关血管认知障碍和痴呆的治疗靶点
  • 批准号:
    10734713
  • 财政年份:
    2023
  • 资助金额:
    $ 0.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了